Jeff Yass’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-26,200
| Closed | -$312K | – | 14417 |
|
|
2026
Q1 | $312K | Sell |
26,200
-78,000
| -75% | -$1.12M | ﹤0.01% | 10774 |
|
|
2025
Q4 | $1.61M | Sell |
104,200
-306,400
| -75% | -$5.63M | ﹤0.01% | 6092 |
|
|
2025
Q3 | $8.89M | Sell |
410,600
-24,900
| -6% | -$555K | ﹤0.01% | 3187 |
|
|
2025
Q2 | $9.68M | Buy |
435,500
+397,500
| +1,046% | +$8.84M | ﹤0.01% | 2880 |
|
|
2025
Q1 | $903K | Buy |
+38,000
| New | +$899K | ﹤0.01% | 7504 |
|
|
2024
Q4 | – | Sell |
-26,000
| Closed | -$838K | – | 13113 |
|
|
2024
Q3 | $838K | Buy |
26,000
+15,900
| +157% | +$470K | ﹤0.01% | 7227 |
|
|
2024
Q2 | $240K | Sell |
10,100
-57,800
| -85% | -$1.48M | ﹤0.01% | 9953 |
|
|
2024
Q1 | $2.03M | Buy |
67,900
+3,200
| +5% | +$100K | ﹤0.01% | 5313 |
|
|
2023
Q4 | $2.07M | Sell |
64,700
-15,300
| -19% | -$444K | ﹤0.01% | 5262 |
|
|
2023
Q3 | $2.34M | Buy |
80,000
+41,400
| +107% | +$1.49M | ﹤0.01% | 4837 |
|
|
2023
Q2 | $1.74M | Buy |
38,600
+17,000
| +79% | +$649K | ﹤0.01% | 5440 |
|
|
2023
Q1 | $745K | Buy |
+21,600
| New | +$701K | ﹤0.01% | 7574 |
|
|
2022
Q3 | – | Sell |
-8,400
| Closed | -$243K | – | 14026 |
|
|
2022
Q2 | $243K | Buy |
+8,400
| New | +$367K | ﹤0.01% | 10140 |
|
|
2022
Q1 | – | Sell |
-19,500
| Closed | -$1.04M | – | 13874 |
|
|
2021
Q4 | $1.04M | Sell |
19,500
-9,800
| -33% | -$455K | ﹤0.01% | 7186 |
|
|
2021
Q3 | $1.24M | Buy |
29,300
+200
| +0.7% | +$10.2K | ﹤0.01% | 6992 |
|
|
2021
Q2 | $1.94M | Buy |
29,100
+3,700
| +15% | +$201K | ﹤0.01% | 5987 |
|
|
2021
Q1 | $1.12M | Buy |
25,400
+15,400
| +154% | +$572K | ﹤0.01% | 7432 |
|
|
2020
Q4 | $290K | Sell |
10,000
-5,000
| -33% | -$124K | ﹤0.01% | 9332 |
|
|
2020
Q3 | $329K | Buy |
15,000
+4,700
| +46% | +$83.5K | ﹤0.01% | 8518 |
|
|
2020
Q2 | $119K | Buy |
+10,300
| New | +$113K | ﹤0.01% | 9408 |
|
|
2018
Q4 | – | Sell |
-20,000
| Closed | -$330K | – | 9863 |
|
|
2018
Q3 | $330K | Buy |
+20,000
| New | +$319K | ﹤0.01% | 7307 |
|
|
2018
Q1 | – | Sell |
-10,900
| Closed | -$132K | – | 10082 |
|
|
2017
Q4 | $132K | Sell |
10,900
-6,300
| -37% | -$60.2K | ﹤0.01% | 8574 |
|
|
2017
Q3 | $178K | Buy |
17,200
+2,800
| +19% | +$40K | ﹤0.01% | 8102 |
|
|
2017
Q2 | $328K | Sell |
14,400
-400
| -3% | -$8.22K | ﹤0.01% | 7419 |
|
|
2017
Q1 | $289K | Buy |
+14,800
| New | +$288K | ﹤0.01% | 7400 |
|
Other funds holding SGRY
BCI
JT
PCM
KSCM
Jeff Yass's SGRY Position: Q2 2026 in Review
Jeff Yass increased its Surgery Partners (SGRY) stake by 131% in Q2 2026, buying an estimated $870K and bringing the position to 109,264 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #6684.
Jeff Yass first reported a position in SGRY in Q4 2015 and has held it in 29 quarters since. The position peaked at $22.7M in Q2 2023. 186 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.
- Jeff Yass held 109,264 shares of Surgery Partners worth $1.84M as of Q2 2026.
- Jeff Yass bought 61,960 Surgery Partners shares in Q2 2026, an estimated $870K.
- Surgery Partners made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6684 holding.
- Jeff Yass first reported a position in Surgery Partners in Q4 2015 and has held it in 29 quarters since.
- Jeff Yass's Surgery Partners position peaked at $22.7M in Q2 2023.
- 186 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.